Our projects

Enhancing data use for pandemic preparednessThe FORTRESS-SSA project is strengthening data-use capabilities within the public health workforce in sub-Saharan Africa, to promote the use of...

Stratifying care of hospitalised childrenThe PediSEP1 project is testing an approach to identify low-risk children who can be safely discharged from the hospital, allowing clinical attention...

Advancing test-and-treat strategies for vivax malariaThe PvSeroRDT project is exploring whether a new diagnostic test for Plasmodium vivax could underpin a test-and-treat strategy for this...

Enhancing detection of tuberculosis drug resistanceThe R2D2-xDRTB project is creating a platform to simultaneously evaluate multiple tools for detecting resistance to commonly used TB drugs.

Simplifying malaria treatmentThe WANECAM 3 project is advancing novel non-artemisinin drug combinations as potential innovative single-dose treatments for malaria.

Enhancing clinical research during outbreaksThe ACT-PREP project aims to strengthen capacity for conducting clinical trials in sub-Saharan Africa, with a particular focus on research during...

Improving treatment of cutaneous leishmaniasisThe MAMS4CL project is establishing a clinical trial platform to test improved treatments for cutaneous leishmaniasis, a parasitic disease that...

Advancing modelling capacity to control emerging and re-emerging infectious diseasesThe TIMERA project is strengthening national capacities to use modelling to address the challenges posed...

Monitoring mpox vaccine activity in AfricaThe MpoxVax AFRIVAC project is closing key knowledge gaps on the performance of mpox vaccines in Central Africa.

Building capacity in new drug developmentThe PACoPPDeT project is developing a cohort of researchers with a deep understanding of all aspects of pharmaceutical product development.

Extending ivermectin use to young childrenThe IVM-KIDS project is developing a child-friendly formulation of ivermectin to ensure young children can benefit from this key drug for parasite...

Repurposing fusidic acid for onchocerciasis controlThe FAME project is assessing whether a repurposed antibiotic could improve control of onchocerciasis (river blindness).

TB prevention in people living with diabetesThe EDCTP2-funded PROTID project has received additional Global Health EDCTP3 funding, enabling it to complete its trial of preventive TB...

Protecting antibiotic potencyThe ASPIRE project is assessing whether improved infection prevention and control, coupled with more personalised antibiotic use, can reduce pressures driving...

Targeting vectors for infection prediction and controlThe IMPACTING project is collecting data on a host of insect vectors that spread infections to help better predict the risk of...

Rapid testing of urinary tract infectionsThe UTI-Diag project is exploring whether point-of-care tests could improve detection and management of urinary tract infections (UTIs) and reduce...

Understanding mpox virus infectionsThe MOVIE-TRACE project is clarifying two key aspects of mpox infections: the speed at which the virus is cleared from the body and its infectiousness.

Antibiotic-based combination therapy for severe malaria and bacterial bloodstream infectionsThe FACT project is developing an innovative treatment that targets both severe malaria and...

Field-testing moxidectin for river blindness controlThe EMINENCE project is exploring whether a newly developed drug, moxidectin, could accelerate the elimination of onchocerciasis (river...